TickerFacts.

Fortrea Holdings Inc. (FTRE): Net Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$986.20M
Year ended 2025-12-31
-$85.20M
Trailing 12 months to 2026-06-30
$186.20M2021-12-31: $98.00M2022-12-31: $186.20M2023-12-31: -$25.20M2024-12-31: -$328.50M2025-12-31: -$986.20M-$986.20M
2021-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$986.20Mn/m2026-02-26, From 2025-01-01
2024-12-31-$328.50Mn/m2026-02-26, From 2024-01-01
2023-12-31-$25.20Mn/m2026-02-26, From 2023-01-01
2022-12-31$186.20Mn/c2025-03-03, From 2022-01-01
2021-12-31$98.00Mn/a2024-03-13, From 2021-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Fortrea Holdings Inc. (FTRE)2025-12-31-$986.20Mn/m
Natera, Inc. (NTRA)2025-12-31-$208.16Mn/m
RadNet, Inc. (RDNT)2025-12-31-$18.65Mn/m
Guardant Health, Inc. (GH)2025-12-31-$416.28Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31-$68.09Mn/m
Quest Diagnostics Inc (DGX)2025-12-31$992.00M+13.9%
Labcorp Holdings Inc. (LH)2025-12-31$876.50M+17.5%
Veracyte, Inc. (VCYT)2025-12-31$66.35M+174.9%
CareDx, Inc. (CDNA)2025-12-31-$21.35Mn/m

Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗